Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis-Reference-Cited by-同舟云学术

Characterization of a multiplex, 12-biomarker test for rheumatoid arthritis

Published:2012-11 Issue: Volume:70 Page:415-424
ISSN:0731-7085
Container-title:Journal of Pharmaceutical and Biomedical Analysis
language:en
Short-container-title:Journal of Pharmaceutical and Biomedical Analysis

Author:

Eastman P. Scott,Manning William C.,Qureshi Ferhan,Haney Douglas,Cavet Guy,Alexander Claire,Hesterberg Lyndal K.

Publisher

Elsevier BV

Subject

Clinical Biochemistry,Spectroscopy,Drug Discovery,Pharmaceutical Science,Analytical Chemistry

Reference29 articles.

1. Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR) and Rheumatoid Arthritis Disease Activity Index (RADAI);Fransen;Arthritis Rheum.,2003

2. Modified disease activity scores that include twenty-eight-joint counts;Prevoo;Arthritis Rheum.,1995

3. Judging disease activity in clinical practice in rheumatoid arthritis: first step in the development of a disease activity score;Van der Heijde;Ann. Rheum. Dis.,1990

4. Preference for endpoint measures in clinical trials: results of structured workshops;Bombardier;J. Rheumatol.,1982

5. Limitations of a quantitative swollen and tender joint count to assess and monitor patients with rheumatoid arthritis;Pincus;Bull. NYU Hosp. Joint Dis.,2008

Cited by 75 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analytical validation of a multi‐protein, serum‐based assay for disease activity assessments in multiple sclerosis;PROTEOMICS – Clinical Applications;2023-03-20

2. Recent advancement in sensitive detection of carcinoembryonic antigen using nanomaterials based immunosensors;Surfaces and Interfaces;2023-02

3. IL-31 and IL-33 in rheumatoid arthritis patients;Rheumatology Science and Practice;2022-11-11

4. Analytical validation of a multi-protein, serum-based assay for disease activity assessments in multiple sclerosis;2022-05-25

5. Unraveling heterogeneity within ACPA-negative rheumatoid arthritis: the subgroup of patients with a strong clinical and serological response to initiation of DMARD treatment favor disease resolution;Arthritis Research & Therapy;2022-01-03